A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

NCT05384262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: AZD0780
DRUG: AZD0780
DRUG: AZD0780
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Rosuvastatin

Sponsor

AstraZeneca

Collaborators

[object Object]